Scott M. Rocklage, Director, 10% Owner at Aprea Therapeutics, Inc. (APRE), sold 245,000 shares at $28.75 ($7.0M) on 2020-06-11, disclosed to the SEC on 2020-06-15.
Open-market sale of $7.0M APRE by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.75 | 9,800 | $282K | 4.0% |
| 2 | $28.75 | 235,200 | $6.8M | 96.0% |
| Total | $28.75 avg | 245,000 | $7.0M | 100% |
| Filing → |
| APRE | SELL | 2020-06-18 | $8.0M | — | Filing → |
| APRE | SELL | 2020-05-21 | $9.0M | — | Filing → |
| CRNX | SELL | 2019-06-25 | $5.5M | — | Filing → |